191 related articles for article (PubMed ID: 37686074)
1. Protective Effects of Pituitary Adenylate-Cyclase-Activating Polypeptide on Retinal Vasculature and Molecular Responses in a Rat Model of Moderate Glaucoma.
Patko E; Szabo E; Vaczy A; Molitor D; Tari E; Li L; Csutak A; Toth G; Reglodi D; Atlasz T
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686074
[TBL] [Abstract][Full Text] [Related]
2. Retinoprotective Effects of PACAP Eye Drops in Microbead-Induced Glaucoma Model in Rats.
Szabo E; Patko E; Vaczy A; Molitor D; Csutak A; Toth G; Reglodi D; Atlasz T
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445531
[TBL] [Abstract][Full Text] [Related]
3. Ocular Delivery of PACAP1-27 Protects the Retina From Ischemic Damage in Rodents.
Werling D; Reglodi D; Banks WA; Salameh TS; Kovacs K; Kvarik T; Vaczy A; Kovacs L; Mayer F; Danyadi B; Lokos E; Tamas A; Toth G; Biro Z; Atlasz T
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6683-6691. PubMed ID: 27936470
[TBL] [Abstract][Full Text] [Related]
4. Passage through the Ocular Barriers and Beneficial Effects in Retinal Ischemia of Topical Application of PACAP1-38 in Rodents.
Werling D; Banks WA; Salameh TS; Kvarik T; Kovacs LA; Vaczy A; Szabo E; Mayer F; Varga R; Tamas A; Toth G; Biro Z; Atlasz T; Reglodi D
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335564
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal Injection of PACAP Attenuates Acute Ocular Hypertension-Induced Retinal Injury Via Anti-Apoptosis and Anti-Inflammation in Mice.
Lu P; Shi Y; Ye D; Lu X; Tang X; Cheng L; Xu Y; Huang J
Invest Ophthalmol Vis Sci; 2022 Mar; 63(3):18. PubMed ID: 35293951
[TBL] [Abstract][Full Text] [Related]
6. Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide.
Atlasz T; Werling D; Song S; Szabo E; Vaczy A; Kovari P; Tamas A; Reglodi D; Yu R
J Mol Neurosci; 2019 Jul; 68(3):397-407. PubMed ID: 30542799
[TBL] [Abstract][Full Text] [Related]
7. PACAP attenuates NMDA-induced retinal damage in association with modulation of the microglia/macrophage status into an acquired deactivation subtype.
Wada Y; Nakamachi T; Endo K; Seki T; Ohtaki H; Tsuchikawa D; Hori M; Tsuchida M; Yoshikawa A; Matkovits A; Kagami N; Imai N; Fujisaka S; Usui I; Tobe K; Koide R; Takahashi H; Shioda S
J Mol Neurosci; 2013 Oct; 51(2):493-502. PubMed ID: 23720065
[TBL] [Abstract][Full Text] [Related]
8. The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.
Vaczy A; Reglodi D; Somoskeoy T; Kovacs K; Lokos E; Szabo E; Tamas A; Atlasz T
J Mol Neurosci; 2016 Oct; 60(2):186-94. PubMed ID: 27566170
[TBL] [Abstract][Full Text] [Related]
9. PACAP improves functional outcome in excitotoxic retinal lesion: an electroretinographic study.
Varga B; Szabadfi K; Kiss P; Fabian E; Tamas A; Griecs M; Gabriel R; Reglodi D; Kemeny-Beke A; Pamer Z; Biro Z; Tosaki A; Atlasz T; Juhasz B
J Mol Neurosci; 2011 Jan; 43(1):44-50. PubMed ID: 20567936
[TBL] [Abstract][Full Text] [Related]
10. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-Bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal rats.
Rácz B; Gallyas F; Kiss P; Tamás A; Lubics A; Lengvári I; Röth E; Tóth G; Hegyi O; Verzál Z; Fabricsek C; Reglódi D
Neurotox Res; 2007 Sep; 12(2):95-104. PubMed ID: 17967733
[TBL] [Abstract][Full Text] [Related]
11. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
[TBL] [Abstract][Full Text] [Related]
12. Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.
Szabadfi K; Reglodi D; Szabo A; Szalontai B; Valasek A; Setalo G; Kiss P; Tamas A; Wilhelm M; Gabriel R
Neurotox Res; 2016 Apr; 29(3):432-46. PubMed ID: 26739825
[TBL] [Abstract][Full Text] [Related]
13. Comparison between PACAP- and enriched environment-induced retinal protection in MSG-treated newborn rats.
Kiss P; Atlasz T; Szabadfi K; Horvath G; Griecs M; Farkas J; Matkovits A; Toth G; Lubics A; Tamas A; Gabriel R; Reglodi D
Neurosci Lett; 2011 Jan; 487(3):400-5. PubMed ID: 21050880
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the protective effects of PACAP with cell-specific markers in ischemia-induced retinal degeneration.
Atlasz T; Szabadfi K; Kiss P; Tamas A; Toth G; Reglodi D; Gabriel R
Brain Res Bull; 2010 Mar; 81(4-5):497-504. PubMed ID: 19751807
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration.
Szabadfi K; Danyadi B; Kiss P; Tamas A; Fabian E; Gabriel R; Reglodi D
J Mol Neurosci; 2012 Nov; 48(3):501-7. PubMed ID: 22544514
[TBL] [Abstract][Full Text] [Related]
16. Effects of pituitary adenylate cyclase activating polypeptide and its fragments on retinal degeneration induced by neonatal monosodium glutamate treatment.
Atlasz T; Szabadfi K; Reglodi D; Kiss P; Tamás A; Tóth G; Molnár A; Szabó K; Gábriel R
Ann N Y Acad Sci; 2009 Apr; 1163():348-52. PubMed ID: 19456357
[TBL] [Abstract][Full Text] [Related]
17. PACAP application improves functional outcome of chronic retinal ischemic injury in rats-evidence from electroretinographic measurements.
Danyadi B; Szabadfi K; Reglodi D; Mihalik A; Danyadi T; Kovacs Z; Batai I; Tamas A; Kiss P; Toth G; Gabriel R
J Mol Neurosci; 2014 Nov; 54(3):293-9. PubMed ID: 24723665
[TBL] [Abstract][Full Text] [Related]
18. PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina.
D'Amico AG; Maugeri G; Reitano R; Bucolo C; Saccone S; Drago F; D'Agata V
J Mol Neurosci; 2015 Dec; 57(4):501-9. PubMed ID: 26202258
[TBL] [Abstract][Full Text] [Related]
19. PACAP Is Protective in a Rat Model of Retinopathy of Prematurity.
Kvarik T; Mammel B; Reglodi D; Kovacs K; Werling D; Bede B; Vaczy A; Fabian E; Toth G; Kiss P; Tamas A; Ertl T; Gyarmati J; Atlasz T
J Mol Neurosci; 2016 Oct; 60(2):179-85. PubMed ID: 27561927
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase-activating polypeptide ameliorates vascular dysfunction induced by hyperglycaemia.
Solymar M; Ivic I; Balasko M; Fulop BD; Toth G; Tamas A; Reman G; Koller A; Reglodi D
Diab Vasc Dis Res; 2018 Jul; 15(4):277-285. PubMed ID: 29466879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
